According to research released by the European Centre for Disease Prevention and Control and the European Food Safety Authority, antimicrobials used to treat diseases that can be transmitted between animals and humans, such as campylobacteriosis and salmonellosis, are becoming less effective.
The data, from 2017, showed that resistance to fluoroquinolones, such as ciprofloxacin, was found to be so high in campylobacter bacteria in some countries that these antimicrobials no longer work for the treatment of severe campylobacteriosis cases.
Most countries in the study also reported that salmonella in humans was increasingly resistant to fluoroquinolones while multidrug resistance, resistance to three or more antimicrobials, was high in salmonella found in humans.
Vytenis Andriukaitis, EU commissioner for health and food safety, said: “The report should ring alarm bells. It shows we are entering into a world where more and more common infections become difficult – or even sometimes impossible – to treat. However, ambitious national policies in some countries limiting antimicrobial use have led to a decrease in antimicrobial resistance.”
He urged collaboration to tackle AMR. “Before the alarm bells become a deafening siren, let’s make sure we increasingly act all together, in every country and across the public health, animal health and environment sectors under the One Health approach umbrella.”